Top Stories
- 23andMe reports sales decline a day after announcing plans to cut 40% of workforce
- Amgen stock falls as analysts mull over weight loss drug’s bone density data
- Asia-Pacific markets open lower after Wall Street postelection rally fizzles
- David Einhorn to speak as the priciest market in decades gets even pricier postelection
- Hedge funds performed better under Democratic presidents than Republican ones, history shows
